Small-Cap REIT ETF ...
Health Care: Drugs
Meridian Bioscience Inc. (VIVO: NASDAQ)
$22.01 0.31 | 1.43%
05/17/13 - 04:00 PM ET
Portfolios with VIVO
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorHighest-Yielding Drug Stocks
- Userhulkkims Portfolio 1
- ContributorBarron's Insider Purchases ...
- UserSUPRATRADE 20 Dividend Stoc...
- UserSUPRATRADE HOT STOCKS (BUY ...
- ContributorDividend Stocks for the Wee...
- Userrussbow98 Portfolio 1
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
Latest VIVO Headlines from TheStreet
- Meridian Bioscience Inc. Stock Upgraded (VIVO) 10.15.12 | 05:10 am
- Meridian Bioscience Inc. Stock Downgraded (VIVO) 08.22.12 | 05:08 am
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 05.01.12 | 09:05 am
- 8 Stocks Rising on Huge Volume 04.20.12 | 01:04 pm
- Meridian Bioscience Inc. Stock Upgraded (VIVO) 03.29.12 | 05:03 am
- Meridian Bioscience Rises On Unusually High Volume (VIVO) 02.01.12 | 03:02 pm
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 01.31.12 | 09:01 am
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 11.16.11 | 10:11 am
- Meridian Bioscience Stock Hits New 52-Week Low (VIVO) 10.03.11 | 09:10 am
- Meridian Bioscience Stock Hits New 52-Week Low (VIVO) 09.21.11 | 02:09 pm
Press Releases for VIVO
- Meridian Bioscience Recognized By Forbes As One Of America’s 100 Most Trustworthy Companies - Business Wire 03.28.13 | 11:03 am
- Meridian Bioscience Announces Illumigene® Group A Streptococcus And Illumigene® Group B Streptococcus Tests Categorized “Moderate Complexity” By FDA - Business Wire 03.18.13 | 11:03 am
- Bioline Launches ISOLATE II, A Precious Find For DNA And RNA Isolation - Business Wire 02.06.13 | 07:02 am
- Meridian Bioscience Reports First Quarter 2013 Operating Results And Reaffirms Fiscal 2013 Guidance - Business Wire 01.23.13 | 07:01 am
- Meridian Bioscience Successfully Completes Beta Trials For Two New Illumigene® Tests - Business Wire 12.13.12 | 02:12 pm
- Meridian Bioscience, Inc. Declares Regular Quarterly Dividend And Accelerates Payment Date To December 24, 2012 - Business Wire 12.04.12 | 10:12 am
- SensiFAST™ Genotyping Kit Exceed The Limit - Business Wire 11.28.12 | 07:11 am
- Meridian Bioscience Reports Fourth Quarter And Full-Year 2012 Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2013 Guidance - Business Wire 11.08.12 | 07:11 am
- Meridian Bioscience Receives FDA Clearance For New Molecular Test: Illumigene® Group A Strep - Business Wire 09.17.12 | 03:09 pm
- Meridian Bioscience Provides Sales And Earnings Guidance For Fiscal 2013 And Reaffirms Fiscal 2012 Guidance - Business Wire 08.28.12 | 07:08 am
Partner Headlines for VIVO
- FDA Clears Meridian Ilumigene GAS - Analyst Blog - NASDAQ 09.20.12 | 04:09 pm
- Gilead REITERATED a Top Pick and 4 Stock Analyses Trending Now - Wall St. Cheat Sheet 07.27.12 | 12:07 pm
- Starbucks DOWNGRADED to Neutral and 4 Downgraded Shares Attracting Attention - Wall St. Cheat Sheet 07.27.12 | 03:07 am
- Meridian Bioscience Receives FDA Clearance for New Legionella Test - Benzinga 02.27.12 | 01:02 pm
- UPDATE: Wedbush Downgrades Meridian Bioscience to Underperform - Benzinga 01.31.12 | 09:01 am
- Dividend Stocks That Combine Growth And Income - Seeking Alpha 01.20.12 | 08:01 am
- FDA OKs Meridian's GDH Test - Analyst Blog - Zacks 01.05.12 | 10:01 am
- 30 'Overdue' Dividend Increases -- Will History Repeat Itself? - Seeking Alpha 08.19.11 | 06:08 pm
- FDA OKs Meridian C. difficile Test - Analyst Blog - Zacks 05.13.11 | 09:05 am
- Meridian Bioscience: An Overvalued Dividend Contender - Seeking Alpha 04.12.11 | 06:04 am
